Global and United States Biologicals for Systemic Lupus Erythematosus Market Report & Forecast 2023-2028

Report ID: 1869277 | Published Date: Jan 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Biologicals for Systemic Lupus Erythematosus Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Biologicals for Systemic Lupus Erythematosus Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Biologicals for Systemic Lupus Erythematosus Market Size for the Year 2017-2028
        1.2.2 Global Biologicals for Systemic Lupus Erythematosus Market Size for the Year 2017-2028
    1.3 Biologicals for Systemic Lupus Erythematosus Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Biologicals for Systemic Lupus Erythematosus in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Biologicals for Systemic Lupus Erythematosus Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Biologicals for Systemic Lupus Erythematosus Market Dynamics
        1.4.1 Biologicals for Systemic Lupus Erythematosus Industry Trends
        1.4.2 Biologicals for Systemic Lupus Erythematosus Market Drivers
        1.4.3 Biologicals for Systemic Lupus Erythematosus Market Challenges
        1.4.4 Biologicals for Systemic Lupus Erythematosus Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Biologicals for Systemic Lupus Erythematosus by Type
    2.1 Biologicals for Systemic Lupus Erythematosus Market Segment by Type
        2.1.1 Rituximab
        2.1.2 Belimumab
        2.1.3 Anifrolumab
        2.1.4 UBP-1213
        2.1.5 Other
    2.2 Global Biologicals for Systemic Lupus Erythematosus Market Size by Type (2017, 2022 & 2028)
    2.3 Global Biologicals for Systemic Lupus Erythematosus Market Size by Type (2017-2028)
    2.4 United States Biologicals for Systemic Lupus Erythematosus Market Size by Type (2017, 2022 & 2028)
    2.5 United States Biologicals for Systemic Lupus Erythematosus Market Size by Type (2017-2028)
3 Biologicals for Systemic Lupus Erythematosus by Application
    3.1 Biologicals for Systemic Lupus Erythematosus Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Pharmacy
        3.1.4 Other
    3.2 Global Biologicals for Systemic Lupus Erythematosus Market Size by Application (2017, 2022 & 2028)
    3.3 Global Biologicals for Systemic Lupus Erythematosus Market Size by Application (2017-2028)
    3.4 United States Biologicals for Systemic Lupus Erythematosus Market Size by Application (2017, 2022 & 2028)
    3.5 United States Biologicals for Systemic Lupus Erythematosus Market Size by Application (2017-2028)
4 Global Biologicals for Systemic Lupus Erythematosus Competitor Landscape by Company
    4.1 Global Biologicals for Systemic Lupus Erythematosus Market Size by Company
        4.1.1 Top Global Biologicals for Systemic Lupus Erythematosus Companies Ranked by Revenue (2021)
        4.1.2 Global Biologicals for Systemic Lupus Erythematosus Revenue by Player (2017-2022)
    4.2 Global Biologicals for Systemic Lupus Erythematosus Concentration Ratio (CR)
        4.2.1 Biologicals for Systemic Lupus Erythematosus Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Biologicals for Systemic Lupus Erythematosus in 2021
        4.2.3 Global Biologicals for Systemic Lupus Erythematosus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Biologicals for Systemic Lupus Erythematosus Headquarters, Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Biologicals for Systemic Lupus Erythematosus Headquarters and Area Served
        4.3.2 Global Biologicals for Systemic Lupus Erythematosus Companies Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Biologicals for Systemic Lupus Erythematosus Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Biologicals for Systemic Lupus Erythematosus Market Size by Company
        4.5.1 Top Biologicals for Systemic Lupus Erythematosus Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Biologicals for Systemic Lupus Erythematosus Revenue by Players (2020, 2021 & 2022)
5 Global Biologicals for Systemic Lupus Erythematosus Market Size by Region
    5.1 Global Biologicals for Systemic Lupus Erythematosus Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Biologicals for Systemic Lupus Erythematosus Market Size by Region (2017-2028)
        5.2.1 Global Biologicals for Systemic Lupus Erythematosus Market Size by Region: 2017-2022
        5.2.2 Global Biologicals for Systemic Lupus Erythematosus Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth 2017-2028
        6.1.2 North America Biologicals for Systemic Lupus Erythematosus Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Biologicals for Systemic Lupus Erythematosus Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth 2017-2028
        6.3.2 Europe Biologicals for Systemic Lupus Erythematosus Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth 2017-2028
        6.4.2 Latin America Biologicals for Systemic Lupus Erythematosus Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Biologicals for Systemic Lupus Erythematosus Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Biologicals for Systemic Lupus Erythematosus Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Company Details
        7.1.2 Roche Business Overview
        7.1.3 Roche Biologicals for Systemic Lupus Erythematosus Introduction
        7.1.4 Roche Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
        7.1.5 Roche Recent Development
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Company Details
        7.2.2 GlaxoSmithKline Business Overview
        7.2.3 GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Introduction
        7.2.4 GlaxoSmithKline Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
        7.2.5 GlaxoSmithKline Recent Development
    7.3 Shanghai Junshi Biosciences
        7.3.1 Shanghai Junshi Biosciences Company Details
        7.3.2 Shanghai Junshi Biosciences Business Overview
        7.3.3 Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Introduction
        7.3.4 Shanghai Junshi Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
        7.3.5 Shanghai Junshi Biosciences Recent Development
    7.4 ACEA Biosciences
        7.4.1 ACEA Biosciences Company Details
        7.4.2 ACEA Biosciences Business Overview
        7.4.3 ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Introduction
        7.4.4 ACEA Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
        7.4.5 ACEA Biosciences Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Biologicals for Systemic Lupus Erythematosus Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Biologicals for Systemic Lupus Erythematosus Market Trends
    Table 3. Biologicals for Systemic Lupus Erythematosus Market Drivers
    Table 4. Biologicals for Systemic Lupus Erythematosus Market Challenges
    Table 5. Biologicals for Systemic Lupus Erythematosus Market Restraints
    Table 6. Global Biologicals for Systemic Lupus Erythematosus Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Biologicals for Systemic Lupus Erythematosus Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Biologicals for Systemic Lupus Erythematosus Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Biologicals for Systemic Lupus Erythematosus Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Biologicals for Systemic Lupus Erythematosus Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Biologicals for Systemic Lupus Erythematosus Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Player, 2017-2022
    Table 13. Global Biologicals for Systemic Lupus Erythematosus Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Biologicals for Systemic Lupus Erythematosus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologicals for Systemic Lupus Erythematosus as of 2021)
    Table 15. Top Players of Biologicals for Systemic Lupus Erythematosus in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Biologicals for Systemic Lupus Erythematosus Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Biologicals for Systemic Lupus Erythematosus Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Biologicals for Systemic Lupus Erythematosus Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Biologicals for Systemic Lupus Erythematosus Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Biologicals for Systemic Lupus Erythematosus Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Biologicals for Systemic Lupus Erythematosus Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Biologicals for Systemic Lupus Erythematosus Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Biologicals for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Biologicals for Systemic Lupus Erythematosus Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Biologicals for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Biologicals for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Biologicals for Systemic Lupus Erythematosus Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Biologicals for Systemic Lupus Erythematosus Product
    Table 33. Roche Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. GlaxoSmithKline Company Details
    Table 36. GlaxoSmithKline Business Overview
    Table 37. GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Product
    Table 38. GlaxoSmithKline Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 39. GlaxoSmithKline Recent Development
    Table 40. Shanghai Junshi Biosciences Company Details
    Table 41. Shanghai Junshi Biosciences Business Overview
    Table 42. Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Product
    Table 43. Shanghai Junshi Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 44. Shanghai Junshi Biosciences Recent Development
    Table 45. ACEA Biosciences Company Details
    Table 46. ACEA Biosciences Business Overview
    Table 47. ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Product
    Table 48. ACEA Biosciences Revenue in Biologicals for Systemic Lupus Erythematosus Business (2017-2022) & (US$ Million)
    Table 49. ACEA Biosciences Recent Development
    Table 50. Research Programs/Design for This Report
    Table 51. Key Data Information from Secondary Sources
    Table 52. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biologicals for Systemic Lupus Erythematosus Product Picture
    Figure 2. Global Biologicals for Systemic Lupus Erythematosus Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Biologicals for Systemic Lupus Erythematosus Market Size 2017-2028 (US$ Million)
    Figure 4. United States Biologicals for Systemic Lupus Erythematosus Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Biologicals for Systemic Lupus Erythematosus Market Size 2017-2028 (US$ Million)
    Figure 6. United States Biologicals for Systemic Lupus Erythematosus Market Share in Global 2017-2028
    Figure 7. Biologicals for Systemic Lupus Erythematosus Report Years Considered
    Figure 8. Product Picture of Rituximab
    Figure 9. Product Picture of Belimumab
    Figure 10. Product Picture of Anifrolumab
    Figure 11. Product Picture of UBP-1213
    Figure 12. Product Picture of Other
    Figure 13. Global Biologicals for Systemic Lupus Erythematosus Market Share by Type in 2022 & 2028
    Figure 14. Global Biologicals for Systemic Lupus Erythematosus Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Biologicals for Systemic Lupus Erythematosus Market Share by Type (2017-2028)
    Figure 16. United States Biologicals for Systemic Lupus Erythematosus Market Share by Type in 2022 & 2028
    Figure 17. United States Biologicals for Systemic Lupus Erythematosus Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Biologicals for Systemic Lupus Erythematosus Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Product Picture of Pharmacy
    Figure 22. Product Picture of Other
    Figure 23. Global Biologicals for Systemic Lupus Erythematosus Market Share by Application in 2022 & 2028
    Figure 24. Global Biologicals for Systemic Lupus Erythematosus Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Biologicals for Systemic Lupus Erythematosus Market Share by Application (2017-2028)
    Figure 26. United States Biologicals for Systemic Lupus Erythematosus Market Share by Application in 2022 & 2028
    Figure 27. United States Biologicals for Systemic Lupus Erythematosus Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Biologicals for Systemic Lupus Erythematosus Market Share by Application (2017-2028)
    Figure 29. North America Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Biologicals for Systemic Lupus Erythematosus Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Roche Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 59. Shanghai Junshi Biosciences Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 60. ACEA Biosciences Revenue Growth Rate in Biologicals for Systemic Lupus Erythematosus Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
GlaxoSmithKline
Shanghai Junshi Biosciences
ACEA Biosciences
Frequently Asked Questions
Biologicals for Systemic Lupus Erythematosus report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biologicals for Systemic Lupus Erythematosus report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biologicals for Systemic Lupus Erythematosus report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Belimumab

Belimumab market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Hydrocortisone

Hydrocortisone market is segmented by region (country), players, by Type and by Application. Play ... Read More

Pyrotinib

Pyrotinib market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Ribociclib

Ribociclib market is segmented by region (country), players, by Type and by Application. Players, ... Read More